Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burger

Showing results (1021-1030 of 1,155) with videos related to

Pageof 116
Sort By:
Nature Communications|December 21, 2017
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapyDan A Landau, Clare Sun, Daniel Rosebrock, et al.
Lancet (London, England)|February 3, 2020
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countriesKaren Canfell, Jane J Kim, Marc Brisson, et al.
Gynecologic Oncology|October 8, 2021
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancerPayal D Shah, Stephanie L Wethington, Cheyenne Pagan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group StudyBarbara M Norquist, Mark F Brady, Maria I Harrell, et al.
British Journal of Haematology|September 12, 2015
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphomaKoichi Takahashi, Mariela Sivina, Julia Hoellenriegel, et al.
NPJ Vaccines|March 30, 2025
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaquesHélène Letscher, Delphine Guilligay, Gregory Effantin, et al.
Drugs|January 12, 2023
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface MalignanciesNiels A D Guchelaar, Bo J Noordman, Stijn L W Koolen, et al.
Blood|January 24, 2018
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomideKoichi Takahashi, Boyu Hu, Feng Wang, et al.
BMC Cancer|September 7, 2023
Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trialHidde Swartjes, Seyed M Qaderi, Steven Teerenstra, et al.
Annals of Surgical Oncology|January 24, 2026
Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II TrialTeun B M van den Heuvel, Paulien Rauwerdink, Emma Hulshof, et al.
Pageof 116

Showing results (1021-1030 of 1,155) with videos related to

Sort By:
Pageof 116
Nature Communications|December 21, 2017
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapyDan A Landau, Clare Sun, Daniel Rosebrock, et al.
Lancet (London, England)|February 3, 2020
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countriesKaren Canfell, Jane J Kim, Marc Brisson, et al.
Gynecologic Oncology|October 8, 2021
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancerPayal D Shah, Stephanie L Wethington, Cheyenne Pagan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group StudyBarbara M Norquist, Mark F Brady, Maria I Harrell, et al.
British Journal of Haematology|September 12, 2015
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphomaKoichi Takahashi, Mariela Sivina, Julia Hoellenriegel, et al.
NPJ Vaccines|March 30, 2025
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaquesHélène Letscher, Delphine Guilligay, Gregory Effantin, et al.
Drugs|January 12, 2023
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface MalignanciesNiels A D Guchelaar, Bo J Noordman, Stijn L W Koolen, et al.
Blood|January 24, 2018
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomideKoichi Takahashi, Boyu Hu, Feng Wang, et al.
BMC Cancer|September 7, 2023
Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trialHidde Swartjes, Seyed M Qaderi, Steven Teerenstra, et al.
Annals of Surgical Oncology|January 24, 2026
Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II TrialTeun B M van den Heuvel, Paulien Rauwerdink, Emma Hulshof, et al.
Pageof 116